Physician profile

Ilana Kutinsky

Clinical Cardiac Electrophysiology · Troy, MI

NPI 1821089087

$137,686.65

in general payments reported to CMS, 2019-2025

31 companies · $62K in 2025

The $62K reported for 2025 was more than what 96% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

See the full distribution for Clinical Cardiac Electrophysiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$51,188.00
Travel and Lodging$23,098.94
Food and Beverage$12,935.22
Consulting Fee$12,500.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $82,082.91 2021-2025 Pulseselect, Evera Mri Xt Dr Surescan, Diamondtemp Bidirectional Ablation Catheter
Boston Scientific Corporation $34,801.52 2019-2025 Farapulse, Watchman, Watchman Flx
Medtronic Vascular, INC. $7,178.82 2019-2020
Abbott Laboratories $5,115.65 2019-2025 Aveir, Ensite, Gallant
Biosense Webster, INC. $4,939.57 2019-2025 Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $645.69 2019-2025 Lifevest
Novartis Pharmaceuticals Corporation $393.69 2019-2021
Janssen Pharmaceuticals, INC $386.01 2019-2024 Xarelto
Amgen INC. $348.75 2019-2022
Sanofi-Aventis U.S. LLC $318.87 2019-2023
E.R. Squibb & Sons, L.L.C. $271.71 2019-2025 Camzyos
Edwards Lifesciences Corporation $236.29 2020-2025 Evoque
Pfizer INC. $145.12 2019-2025
Cardiofocus, INC. $116.26 2019-2022
Impulse Dynamics (USA) INC. $90.08 2022-2023 Optimizer
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Preventice Services, LLC $88.80 2019-2021
Bardy Diagnostics, INC. $84.85 2020-2021
Astrazeneca Pharmaceuticals LP $76.01 2020-2024 Brilinta
Kestra Medical Technology Services, INC. $75.90 2024-2025 Assure Wcd
Cordis US Corp. $56.56 2023-2025 Mynx Control Venous, Mynx Control, Mynx Venous Vcd
Kiniksa Pharmaceuticals International, Plc $36.33 2024 Arcalyst
Irhythm Technologies, INC. $36.33 2019-2023 Zio Xt Patch
Amarin Pharma, INC. $31.10 2019-2021
Biotronik INC. $29.62 2019
Braemar Manufacturing, LLC $22.74 2019
Glaxosmithkline, LLC. $20.85 2025 Shingrix
Regeneron Healthcare Solutions, INC. $19.50 2019
Alnylam Pharmaceuticals INC. $13.82 2020
Gilead Sciences, INC. $12.03 2019
W. L. Gore & Associates, INC. $11.27 2019

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ilana Kutinsky

$137,686.65

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $62K reported for 2025 was more than what 96% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/354517/ilana-kutinsky

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.